Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

MABT879

Sigma-Aldrich

Anti-Thrombospondin-1 Antibody, clone 133

clone 133, from mouse

Sinónimos:

Thrombospondin-1, THBS-1, TSP-1

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Código UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.41

origen biológico

mouse

Nivel de calidad

forma del anticuerpo

purified immunoglobulin

tipo de anticuerpo

primary antibodies

clon

133, monoclonal

reactividad de especies

rat, human

técnicas

ELISA: suitable
immunohistochemistry: suitable (paraffin)
neutralization: suitable
western blot: suitable

isotipo

IgG2bκ

Nº de acceso NCBI

Nº de acceso UniProt

Condiciones de envío

dry ice

modificación del objetivo postraduccional

unmodified

Información sobre el gen

human ... THBS1(7057)

Descripción general

Thrombospondin-1 (UniProt P07996; also known as THBS-1, TSP-1) is encoded by the THBS1 (also known as THBS, TSP, TSP1) gene (Gene ID 7057) in human. Thrombospondin-1 (TSP-1) is a member of the TSP family of calcium-binding extracellular matrix proteins. The TSP family consists of the homotrimeric TSP-1 and TSP-2, as well as the homopentameric TSP-3, TSP-4 and TSP-5/COMP (cartilage oligomeric matrix protein). TSP-1 is induced at injury site and functions as an activator of latent TGF-β. TSP-1 binding alters the conformation of the latent TGF-β complex and renders TGF-β biologically active, which in turn can also induce TSP-1 expression. TSP-1 mediates the proliferation of fibroblasts and smooth muscle cells, while it inhibits the proliferation of endothelial cells. TSP-1 may also serve as both an attachment protein and an anti-adhesive molecule as shown by its ability to cause disassembly of focal adhesions of endothelial cells. TSP-1 is initially produced with a signal peptide sequence (a.a. 1-18), the removal of which yields the mature protein (a.a. 19-1170). Structurally, TSP-1 monomer consists of a N-terminal heparin-binding (a.a. 47-95) region and a laminin G-like domain (a.a. 65-270), followed by an oligomerization domain (a.a. 259-311), a procollagen or VWFC domain (a.a. 316-373), three properdin or type I repeats (a.a. 379-429, 435-490, and 492-547), two EGF-like domains (a.a. 547-587 and 646-690), eight type III repeats or calcium-wire module (a.a. 691-954), and a C-terminal lectin-like globular module or G domain (a.a. 958-170).

Especificidad

Clone 133 reacted with human thrombospondin-1 (hTSP-1), but not hTSP-2, mouse TSP-1 (mTSP-1), or mTSP-2. Clone 133 detected the C-terminal 50 kDa chymotryptic fragment of stripped TSP as well as recominant fragements containing the Calcium-binding type-3 repeats (a.a. 692-945) region (Annis, D.S., et al. (2006). J. Thromb. Haemost. 4(2):459-468; Schultz-Cherry, S., and Murphy-Ullrich J.E. (1993). J. Cell Biol. 122(4):923-932).

Inmunógeno

Alkaline-stripped human platelet thrombospondin-1 (sTSP-1).
Epitope: Calcium-binding type-3 repeats.

Aplicación

Detect Thrombospondin-1 using this Anti-Thrombospondin-1 Antibody, clone 133 validated for use in Western Blotting, Immunohistochemistry (Paraffin), Neutralizing, ELISA.
Research Category
Cell Structure
Research Sub Category
ECM Proteins
Western Blotting Analysis: A representative lot detected an upregulated thrombospondin-1 (TSP-1) expression in cultured primary rat vascular smooth muscle cells (VSMCs) upon treatment with either stainless steel (SS) ions or active TGF-β (Pallero, M.A., et al. (2010). J. Vasc. Res. 47(4):309-322).
Western Blotting Analysis: A representativev lot ditected full-length human thrombospondin-1 (hTSP-1) as well as hTSP-1 C-terminal fragments E3CaG (a.a. 648-1170), E3Ca (a.a. 648-945) and Ca (a.a. 692-945), but not hTSP-2, mouse TSP-1 (mTSP-1), or mTSP-2 by Western blotting under either reducing or non-reducing condition (Annis, D.S., et al. (2006). J. Thromb. Haemost. 4(2):459-468).
Western Blotting Analysis: A representative lot detected an upregulated thrombospondin-1 (TSP-1) in human pancreatic cancer Panc-1 cells upon siRNA-mediatted k-Ras knockdown (Fleming, J.B., et al. (2005). Mol. Cancer Res. 3(7):413-423).
Immunohistochemistry Analysis: A representative lot detected elevated thrombospondin-1 (TSP-1) immunoreactivity in vascular tissues surrounding stent materials due to in-stent restenosis (ISR) in paraffin-embedded sections of human coronary arteries from patients received either Taxus or Cypher drug-eluting stent implant (Pallero, M.A., et al. (2010). J. Vasc. Res. 47(4):309-322).
Neutralizing Analysis: Representative lots prevented alkaline-stripped human platelet thrombospondin-1 (sTSP-1) from activatating the latent form of TGF-beta secreted by cultured NMuMG murine mammary gland epithelial cells or bovine aortic endothelial (BAE) cells without affecting cellular signaling induced by the mature/active form of TGF-beta (Alcaraz, L.B., et al. (2014). J. Cell Biol. 205(3):409-428; Annis, D.S., et al. (2006). J. Thromb. Haemost. 4(2):459-468; Schultz-Cherry, S., and Murphy-Ullrich J.E. (1993). J. Cell Biol. 122(4):923-932).
Neutralizing Analysis: A representative lot inhibited stainless steel (SS) ions-induced TGF-β signaling in cultured primary rat vascular smooth muscle cells (VSMCs) as indicated by a suppressed induction of the synthetic/myofibroblastic protein ED-A FN (Pallero, M.A., et al. (2010). J. Vasc. Res. 47(4):309-322).
ELISA Analysis: A representativev lot ditected full-length human thrombospondin-1 (hTSP-1) as well as hTSP-1 C-terminal fragments E3CaG (a.a. 648-1170) and E3Ca (a.a. 648-945), but not hTSP-2, mouse TSP-1 (mTSP-1), or mTSP-2 by direct/non-sandwich ELISA (Annis, D.S., et al. (2006). J. Thromb. Haemost. 4(2):459-468).

Calidad

Evaluated by Western Blotting in human thrombospondin-1 purified protein.

Western Blotting Analysis: 0.1 µg/mL of this antibody detected Thrombospondin-1 in 0.1 µg of human thrombospondin-1 purified protein.

Descripción de destino

~129 kDa observed.

Forma física

Format: Purified
Protein G Purified
Purified mouse monoclonal IgG2bκ antibody in PBS without preservatives.

Almacenamiento y estabilidad

Stable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

Otras notas

Concentration: Please refer to lot specific datasheet.

Cláusula de descargo de responsabilidad

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

¿No encuentra el producto adecuado?  

Pruebe nuestro Herramienta de selección de productos.

Código de clase de almacenamiento

12 - Non Combustible Liquids

Clase de riesgo para el agua (WGK)

WGK 2

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico